Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L30 pseudogene 16 (RPL30P16) is a *processed pseudogene* derived from the parent gene encoding ribosomal protein L30, part of the 60S ribosomal subunit[6][4]. Pseudogenes such as RPL30P16 are genetic elements with sequence similarity to their parent protein-coding genes but are non-functional, typically due to accumulation of disabling mutations or insertion as DNA without necessary regulatory elements[6][4]. Unlike the functional ribosomal protein L30 gene, which encodes a protein involved in protein synthesis within the ribosome[3][5], this pseudogene is not transcribed into a protein and does not have a known physiological role or involvement in disease, drug interactions, or therapeutic applications[6][4][2]. The correct therapeutic target would be "Ribosomal protein L30" (RPL30), not its pseudogene RPL30P16[3][5]. **Key points:** - RPL30P16 is a non-functional pseudogene, not a therapeutic target[6][4]. - It does not belong to common molecular classes such as receptor, enzyme, or transporter. - The entry "RPL30 pseudogene 16" refers to a genetic element with no established biological or pathological function, no role in disease, and no drug targeting or biomarker utility[6][4]. - If your intent was to refer to a ribosomal protein with therapeutic or research relevance, you should specify "Ribosomal protein L30" (RPL30)[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L30 pseudogene 16 (RPL30P16).